The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Del. among states eyeing unclaimed property

November 24, 2010 11:46 am | by RANDALL CHASE - Associated Press - Associated Press | News | Comments

Facing slow economic recovery and the loss of federal stimulus funds used to fill budget gaps, Delaware officials are fighting to defend a key source of revenue: abandoned property.Other cash-strapped states also are taking a more aggressive stance toward recovering abandoned property, which...

Humana spent $281 K lobbying federal gov't in 3Q

November 24, 2010 11:46 am | by The Associated Press | News | Comments

Health insurer Humana Inc. sliced its spending on third-quarter federal lobbying by 69 percent compared to 2009, as it focused on only a handful of Congressional acts.The Louisville, Ky., insurer spent $281,000 in the July to September period, which represented a 4 percent increase from this...

L & L Acquisition prices $40M IPO

November 24, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | News | Comments

L&L Acquisition Corp., an acquisition firm focused on healthcare-related businesses, has priced its initial public offering, filed in July, at $40 million.


Slosman to lead Itamar-Medical's North America division

November 24, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Itamar-Medical Inc., a medical technology company focused on the cardiovascular system, has named Marvin Slosman as president of Itamar-Medical for North America.


Erythromycin A produced in E. coli for first time

November 24, 2010 8:37 am | by EurekAlert | News | Comments

(Tufts University) For the first time, researchers have made the antibiotic erythromycin A, and two variants, using E. coli as the production host. This is a cost-effective way to make erythromycin A and new drugs to combat antibiotic resistant pathogens. The E. coli host also...


Genzyme meets FDA milestone for Allston plant

November 24, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. has met an FDA consent decree milestone, ending its Allston plant's fill/finish operations of four drugs sold in the U.S.

The most aggressive forms of breast cancer elude cellular control mechanisms in order to expand

November 24, 2010 7:31 am | by EurekAlert | News | Comments

(Institute for Research in Biomedicine (IRB Barcelona)) Scientists at IRB Barcelona have provided new data on how certain types of aggressive breast cancer bypass tumor suppression mechanisms.


510(k) Final Decisions - October 2010

November 24, 2010 7:30 am | by U.S. Food & Drug Administration | News | Comments

Page Last Updated: 11/24/2010 Note: If you need help accessing information in different file formats, see Instructions for Downlo


ZoomMed Announces the Filing on Sedar of an Amended Management Proxy Circular

November 24, 2010 6:46 am | by The Associated Press | News | Comments

ZoomMed Inc. (TSX VENTURE: ZMD) announces the filing today on SEDAR of an amended management proxy circular dated November 24, 2010.The amendments made to the document are the result of an observation received from the Autorite des marches financiers du Quebec as part of its continuous...

Piper Jaffray Healthcare Conference on November 30 and Lazard Capital Markets Med Tech/Life Sciences Tools Day on December 2, 2010

November 24, 2010 6:45 am | by The Associated Press | News | Comments () —TomoTherapy Incorporated ( (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that President and CEO Fred Robertson, M.D., will participate in two upcoming...

LifeImage picked for NIH-backed medical imaging project

November 24, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

LifeImage Inc., a Newton-based maker of medical imaging storage and sharing technology, has been chosen by the Radiological Society of North America for a two-year project to establish a digital “clearinghouse” of medical images to be shared among medical centers.

High-Precision Glass Tubes Meet Exacting Specifications

November 24, 2010 5:58 am | Product Releases | Comments

Through their subsidiary, The Technical Glass Co., Goodfellow offers high-precision glass tubes in a wide range of shapes, sizes, and materials for applications where precision is essential, such as in engineering, optical applications, and research.

Power Supply Series Meets Latest Energy Standards

November 24, 2010 5:51 am | XP Power | Product Releases | Comments

XP Power announced the launch of the highly efficient single output AFM series of 48 and 60 Watt external AC-DC power supplies designed for a wide range of medical equipment.

High Pass Filters Have Frequency Ranges From DC to 100 MHz Through 1 GHz

November 24, 2010 5:36 am | Product Releases | Comments

Crystek has introduced a line of high pass filters, the CHPFL Series. Encased in a rugged SMA housing, this filter line is designed for test equipment and general lab use.

Genzyme stops making four U.S. drugs in Allston

November 24, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. has stopped using its Allston plant for fill/finish operations of four drugs sold in the U.S., as part of an FDA consent decree.


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.